-+ 0.00%
-+ 0.00%
-+ 0.00%

Cyclerion Therapeutics to Begin Phase 2 CYC-126 Study in Treatment-Resistant Depression in 2026

Reuters·02/17/2026 12:02:17

Please log in to view news